This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05359445
Recruitment Status : Recruiting
First Posted : May 3, 2022
Last Update Posted : February 22, 2024
Bristol-Myers Squibb
Information provided by (Responsible Party):
Immatics Biotechnologies GmbH

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2025
Estimated Study Completion Date : November 2027